BGLAX | RGFTX | BGLAX / RGFTX | |
Total Expense Ratio | 1.25 | 0.91 | 137% |
Annual Report Gross Expense Ratio | 1.43 | 1.24 | 115% |
Fund Existence | 14 years | 8 years | - |
Gain YTD | 9.869 | 17.723 | 56% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 136M | 352M | 39% |
Annual Yield % from dividends | 1.47 | 3.17 | 46% |
Returns for 1 year | 11.93 | 17.19 | 69% |
Returns for 3 years | 5.74 | 21.48 | 27% |
Returns for 5 years | 31.64 | 24.86 | 127% |
Returns for 10 years | 42.77 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PDBA | 35.94 | 0.50 | +1.41% |
Invesco Agriculture Cmdty Str No K-1ETF | |||
ARKG | 25.24 | 0.16 | +0.64% |
ARK Genomic Revolution ETF | |||
SPMV | 48.96 | 0.04 | +0.07% |
Invesco S&P 500 Minimum Variance ETF | |||
ZSEP | 26.20 | -0.03 | -0.11% |
Innovator Equity Defined Prot ETF-1YrSep | |||
RFV | 123.76 | -1.19 | -0.95% |
Invesco S&P MidCap 400® Pure Value ETF |